Today: 30 April 2026
Nu Holdings stock beats the market in thin year-end trade — what NU investors are watching next
31 December 2025
1 min read

Nu Holdings stock beats the market in thin year-end trade — what NU investors are watching next

NEW YORK, December 30, 2025, 22:12 ET — Market closed

  • Nu Holdings (NU) rose 1.3% to $16.88 on Tuesday, outpacing a 0.14% dip in the S&P 500.
  • Latin America fintech peers StoneCo and Inter & Co gained, while SoFi slipped.
  • Analysts’ forecasts ahead of Nu’s next earnings update are back in focus after the stock’s recent monthly pullback.

Nu Holdings Ltd. (NYSE: NU) shares climbed 1.3% to $16.88 on Tuesday, ending higher even as Wall Street posted a modest decline in the penultimate session of 2025.

The move mattered because liquidity is thin into year-end, which can magnify day-to-day swings and drive fast rotations between crowded trades and laggards.

For Nu, the bounce comes after a weaker month. The stock has fallen about 4.7% over the past four weeks, leaving investors watching whether the next earnings update can reset sentiment.

Nu traded between $16.60 and $17.11 during the session, with about 31.4 million shares changing hands. The S&P 500 slipped 0.14%, while the Nasdaq Composite fell 0.23% and the Dow lost 0.20%, according to a Reuters market wrap.

Other fintech names tied to consumer credit were mixed. StoneCo rose about 1.4% and Inter & Co gained about 1.4%, while SoFi Technologies fell about 1.0%, based on end-of-day market data.

“It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide, commenting on broader year-end positioning.

Nu, which operates the Nubank digital banking platform across Latin America, is often treated as a high-beta proxy for risk appetite in emerging-market fintech.

Analysts tracked by Zacks expect Nu to post earnings per share of $0.18 on its next report, on revenue of $4.56 billion, according to a note republished by Nasdaq on Tuesday. The same note pegged Nu’s forward price-to-earnings ratio — a valuation measure based on expected profits — at about 28.4, and its PEG ratio, which adjusts P/E for expected growth, at roughly 0.8.

Nu’s next earnings date is widely listed as falling in February, with Nasdaq’s earnings page showing an estimated report date of Feb. 19, 2026. Investors typically use that window to look for updates on loan growth, funding costs and credit performance — a key watchpoint for consumer lenders.

Wednesday marks the final trading day of 2025, before U.S. markets close for the New Year’s Day holiday. Volume is likely to stay light, keeping the tape sensitive to positioning.

In the near term, traders will watch whether NU can hold above Tuesday’s $16.60 low and challenge the $17.11 intraday high, which sits near a round-number level that can draw momentum flows.

Beyond the next session, the focus shifts to Nu’s upcoming results and how management frames 2026. Investors will be looking for evidence that customer growth and monetization can stay strong without a rise in delinquencies as the company expands credit across its markets.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Cisco stock slips in year-end trade as Fed minutes keep CSCO investors cautious
Previous Story

Cisco stock slips in year-end trade as Fed minutes keep CSCO investors cautious

Al-Arafah Islami Bank, Provati Insurance sign deal to digitise premium payments in Bangladesh
Next Story

Al-Arafah Islami Bank, Provati Insurance sign deal to digitise premium payments in Bangladesh

Go toTop